These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26655534)

  • 1. Should postnatal oximetry screening be implemented nationwide in China? A cost-effectiveness analysis in three regions with different socioeconomic status.
    Tobe RG; Martin GR; Li F; Mori R
    Int J Cardiol; 2016 Feb; 204():45-7. PubMed ID: 26655534
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost-effectiveness analysis of neonatal screening of critical congenital heart defects in China.
    Tobe RG; Martin GR; Li F; Moriichi A; Wu B; Mori R
    Medicine (Baltimore); 2017 Nov; 96(46):e8683. PubMed ID: 29145300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulse oximetry as a screening test for congenital heart defects in newborn infants: a cost-effectiveness analysis.
    Roberts TE; Barton PM; Auguste PE; Middleton LJ; Furmston AT; Ewer AK
    Arch Dis Child; 2012 Mar; 97(3):221-6. PubMed ID: 22247242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of pulse oximetry screening for critical congenital heart defects following homebirth and early discharge.
    Narayen IC; Te Pas AB; Blom NA; van den Akker-van Marle ME
    Eur J Pediatr; 2019 Jan; 178(1):97-103. PubMed ID: 30334077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening for congenital heart defects: a systematic review and cost-effectiveness analysis.
    Knowles R; Griebsch I; Dezateux C; Brown J; Bull C; Wren C
    Health Technol Assess; 2005 Nov; 9(44):1-152, iii-iv. PubMed ID: 16297355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulse oximetry as a screening test for congenital heart defects in newborn infants: a test accuracy study with evaluation of acceptability and cost-effectiveness.
    Ewer AK; Furmston AT; Middleton LJ; Deeks JJ; Daniels JP; Pattison HM; Powell R; Roberts TE; Barton P; Auguste P; Bhoyar A; Thangaratinam S; Tonks AM; Satodia P; Deshpande S; Kumararatne B; Sivakumar S; Mupanemunda R; Khan KS
    Health Technol Assess; 2012; 16(2):v-xiii, 1-184. PubMed ID: 22284744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating cost and resource use associated with pulse oximetry screening for critical congenital heart disease: Empiric estimates and sources of variation.
    Reeder MR; Kim J; Nance A; Krikov S; Feldkamp ML; Randall H; Botto LD
    Birth Defects Res A Clin Mol Teratol; 2015 Nov; 103(11):962-71. PubMed ID: 26215888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulse oximetry screening for congenital heart defects.
    Ewer AK; Granelli AD; Manzoni P; Sánchez Luna M; Martin GR
    Lancet; 2013 Sep; 382(9895):856-7. PubMed ID: 24012266
    [No Abstract]   [Full Text] [Related]  

  • 9. Important considerations for the newborn: access to postdischarge newborn care, pulse oximetry screening for congenital heart disease, and circumcision.
    Pattishall AE; Spector ND; McPeak KE
    Curr Opin Pediatr; 2014 Dec; 26(6):734-40. PubMed ID: 25259474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse Oximetry Screening for Critical Congenital Heart Defects.
    Wood J
    Neonatal Netw; 2015; 34(3):156-64. PubMed ID: 26802391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for critical congenital heart disease: advancing detection in the newborn.
    Bradshaw EA; Martin GR
    Curr Opin Pediatr; 2012 Oct; 24(5):603-8. PubMed ID: 22935755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the clinical and economic effects of clinical examination, pulse oximetry, and echocardiography in newborn screening for congenital heart defects: a probabilistic cost-effectiveness model and value of information analysis.
    Griebsch I; Knowles RL; Brown J; Bull C; Wren C; Dezateux CA
    Int J Technol Assess Health Care; 2007; 23(2):192-204. PubMed ID: 17493305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pulse oximetry screening of newborns detects congenital heart defects. Experiences from Kalmar].
    Green E; Rosenkvist CJ
    Lakartidningen; 2012 Feb 29-Mar 13; 109(9-10):481-2. PubMed ID: 22530413
    [No Abstract]   [Full Text] [Related]  

  • 14. Cost-effectiveness of routine screening for critical congenital heart disease in US newborns.
    Peterson C; Grosse SD; Oster ME; Olney RS; Cassell CH
    Pediatrics; 2013 Sep; 132(3):e595-603. PubMed ID: 23918890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A public health economic assessment of hospitals' cost to screen newborns for critical congenital heart disease.
    Peterson C; Grosse SD; Glidewell J; Garg LF; Van Naarden Braun K; Knapp MM; Beres LM; Hinton CF; Olney RS; Cassell CH
    Public Health Rep; 2014; 129(1):86-93. PubMed ID: 24381364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulse oximetry screening for critical congenital heart defects in newborn infants: should it be routine?
    Ewer AK
    Arch Dis Child Fetal Neonatal Ed; 2014 Jan; 99(1):F93-5. PubMed ID: 23934364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of the postnatal examination in improving child health.
    Green K; Oddie S
    Arch Dis Child Fetal Neonatal Ed; 2008 Sep; 93(5):F389-93. PubMed ID: 18463120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should New Zealand introduce nationwide pulse oximetry screening for the detection of critical congenital heart disease in newborn infants?
    Cloete E; Gentles TL; Alsweiler JM; Dixon LA; Webster DR; Rowe DL; Bloomfield FH
    N Z Med J; 2017 Jan; 130(1448):64-69. PubMed ID: 28081558
    [No Abstract]   [Full Text] [Related]  

  • 19. Early screening for critical congenital heart defects in asymptomatic newborns in Mazovia province: experience of the POLKARD pulse oximetry programme 2006-2008 in Poland.
    Turska Kmieć A; Borszewska Kornacka MK; Błaż W; Kawalec W; Zuk M
    Kardiol Pol; 2012; 70(4):370-6. PubMed ID: 22528711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of pulse oximetry screening in Middle Tennessee: cases for consideration before universal screening.
    Walsh W
    J Perinatol; 2011 Feb; 31(2):125-9. PubMed ID: 20508595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.